SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,606,491 | -38.4% | 3,344,810 | -17.4% | 0.44% | -46.0% |
| Q2 2023 | $18,826,660 | -6.5% | 4,048,744 | -7.1% | 0.80% | +54.2% |
| Q1 2023 | $20,145,450 | -22.4% | 4,360,487 | +35.8% | 0.52% | -53.8% |
| Q4 2022 | $25,951,926 | +234.0% | 3,211,872 | +129.4% | 1.13% | +189.3% |
| Q3 2022 | $7,770,000 | +65.7% | 1,400,000 | +55.6% | 0.39% | +58.9% |
| Q2 2022 | $4,689,000 | – | 900,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |